| Oct 12 |
Weight loss drugs have one big issue; these companies want to fix it
|
| Oct 11 |
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
|
| Oct 11 |
Here’s What Dragged Novo Nordisk A/S (NVO) in Q3
|
| Oct 11 |
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
|
| Oct 11 |
Warning: This Skyrocketing Stock Has a Hidden Risk
|
| Oct 10 |
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
|
| Oct 10 |
Update: Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent
|
| Oct 10 |
Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent
|
| Oct 10 |
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
|
| Oct 10 |
2 No-Brainer Dividend Growth Stocks to Buy Right Now
|
